Rating History for Cellectar Biosciences (CLRB) by Maxim Group
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/10/2026 | Jason McCarthy | Upgrade | Buy (Hold) |
10.00 (N/A) |
2.75 (2.60) |
-5.45% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/10/2026 | Jason McCarthy | Upgrade | Buy (Hold) |
10.00 (N/A) |
2.75 (2.60) |
-5.45% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||